Trial Profile

An open label, multicentric, dose ranging, single dose study to evaluate safety, tolerability & pharmacokinetics of Cabazitaxel lipid suspension for injection (Manufactured by Intas Pharmaceuticals Ltd.) in comparison with JEVTANA (Cabazitaxel) injection (Manufactured by Sanofi-aventis) in patients with advanced solid malignancies refractory to conventional treatment.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 03 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 Apr 2018 Status changed from recruiting to completed.
15 Jul 2016 New source identified and integrated (Clinical Trials Registry - India CTRI/2015/06/005948)
15 Jul 2016 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com